CV Lattes
ORCID
Abstract
Pancreatic Ductal Adenocarcinoma (PDAC) is one of the most challenging types of cancer exhibiting a lack of targetable pathways. Thus, PDAC has been considered a "graveyard" for drug development. Here we propose an ambitious project which aims to identify new therapeutic targets and develop the first steps of an innovative therapy for PDAC, using relevant models and approaches. For this, …